Stay updated on Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial

Sign up to get notified when there's something new on the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T16:18:52.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces updates and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition.
    Difference
    1%
    Check dated 2026-10-25T19:18:57.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.2 instead of v3.7.1. The page continues to show a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-18T22:34:20.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 on the ClinicalTrials.gov 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-11T22:29:54.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a minimal layout, replacing the previous study-record content and navigation. This indicates the page is currently inaccessible due to permissions.
    Difference
    20%
    Check dated 2026-09-20T22:25:36.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    There are no textual additions or deletions recorded for this page in the provided data.
    Difference
    0.1%
    Check dated 2026-09-13T20:42:12.000Z thumbnail image

Stay in the know with updates to Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page.